Plus, TransFi launches Jarvis for cross-border payment compliance; PwC Canada joins with Alation to develop AI solutions; and other accounting tech news.
Capricor Therapeutics’ CEO Linda Marbán believes the FDA is willing to work with the biotech as the Aug. 22 deadline approaches for its Duchenne muscular dystrophy cell therapy deramiocel, with the biotech’s stock climbing 68% on the update.
Sponsors of the pivotal study behind Amgen’s rare disease drug Tavneos saw unblinded findings for the drug and re-adjudicated data from nine patients to make the drug seem effective, according to European regulators.
Companies that manufacture MDMA and psilocybin for patients in other countries are looking to use their experience to access the potential U.S. market.
Ernst & Young has been ramping up its use of artificial intelligence technology to make its audits more thorough for clients worldwide, while turning auditors into AI developers.
Grassi, a Top 75 Firm based in New York, has added Hoffman Mulligan, strengthening its high-net-worth and tax practice capabilities and expanding its presence in New York City.
The IRS takes a victory lap for customer service in a recent report. But from the standpoint of its most important customers, it isn’t serving them nearly as well.